Literature DB >> 24852215

Chitosan and silver nanoparticles: promising anti-toxoplasma agents.

M R Gaafar1, R F Mady2, R G Diab2, Th I Shalaby3.   

Abstract

Toxoplasmosis is a worldwide infection caused by obligate intracellular protozoan parasite which is Toxoplasma gondii. Chitosan and silver nanoparticles were synthesized to be evaluated singly or combined for their anti-toxoplasma effects as prophylaxis and as treatment in the experimental animals. Results were assessed through studying the parasite density and the ultrastructural parasite changes, and estimation of serum gamma interferon. Weight of tissue silver was assessed in different organs. Results showed that silver nanoparticles used singly or combined with chitosan have promising anti-toxoplasma potentials. The animals that received these compounds showed statistically significant decrease in the mean number of the parasite count in the liver and the spleen, when compared to the corresponding control group. Light microscopic examination of the peritoneal exudates of animals receiving these compounds showed stoppage of movement and deformity in shape of the tachyzoites, whereas, by scanning electron microscope, the organisms were mutilated. Moreover, gamma interferon was increased in the serum of animals receiving these compounds. All values of silver detected in different tissues were within the safe range. Thus, these nanoparticles proved their effectiveness against the experimental Toxoplasma infection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chitosan nanoparticles; Silver nanoparticles; Toxoplasmosis

Mesh:

Substances:

Year:  2014        PMID: 24852215     DOI: 10.1016/j.exppara.2014.05.005

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  22 in total

Review 1.  Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications.

Authors:  João Paulo Assolini; Virginia Márcia Concato; Manoela Daiele Gonçalves; Amanda Cristina Machado Carloto; Ivete Conchon-Costa; Wander Rogério Pavanelli; Francine Nesello Melanda; Idessania Nazareth Costa
Journal:  Parasitol Res       Date:  2017-05-05       Impact factor: 2.289

Review 2.  Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine.

Authors:  Sanaz Jafarpour Azami; Hanieh Mohammad Rahimi; Hamed Mirjalali; Mohammad Reza Zali
Journal:  World J Microbiol Biotechnol       Date:  2021-02-10       Impact factor: 3.312

3.  In Vitro Antiprotozoal Effects of Nano-chitosan on Plasmodium falciparum, Giardia lamblia and Trichomonas vaginalis.

Authors:  Taher Elmi; Bahman Rahimi Esboei; Fatemeh Sadeghi; Zahra Zamani; Mojtaba Didehdar; Mahdi Fakhar; Aroona Chabra; Fateme Hajialiani; Mohammad Javad Namazi; Fatemeh Tabatabaie
Journal:  Acta Parasitol       Date:  2020-07-14       Impact factor: 1.440

4.  Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice.

Authors:  Dalia A Elmehy; Marwa A Hasby Saad; Gamal M El Maghraby; Mona F Arafa; Nema A Soliman; Heba H Elkaliny; Dina I Elgendy
Journal:  Parasitol Res       Date:  2021-05-04       Impact factor: 2.289

5.  Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.

Authors:  Shahira A Ahmed; Heba S El-Mahallawy; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2019-06-11       Impact factor: 2.289

6.  Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.

Authors:  Samia E Etewa; Dalia A Abo El-Maaty; Rania S Hamza; Ashraf S Metwaly; Mohamed H Sarhan; Sara A Abdel-Rahman; Ghada M Fathy; Mahmoud A El-Shafey
Journal:  J Parasit Dis       Date:  2017-12-15

7.  In vitro Effect of Silver Nanoparticles on Blastocystis hominis.

Authors:  Mohamed Saad Younis; Eman Abd El Rahman Abououf; Ali El Saeed Ali; Sara Mohamed Abd Elhady; Rita Maher Wassef
Journal:  Int J Nanomedicine       Date:  2020-10-22

Review 8.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

9.  Effect of Nigella sativa oil on experimental toxoplasmosis.

Authors:  Rasha F Mady; Wessam El-Hadidy; Samar Elachy
Journal:  Parasitol Res       Date:  2015-10-07       Impact factor: 2.289

10.  Anticoccidial activities of Chitosan on Eimeria papillata-infected mice.

Authors:  Mahmoud Abdel-Latif; Heba M Abdel-Haleem; Abdel-Azeem S Abdel-Baki
Journal:  Parasitol Res       Date:  2016-04-04       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.